Leqembi (lecanemab-irmb) - Biogen, Eisai
Imaging for anti-amyloid therapy eligibility: Comparing GRE and SWI in detecting microhemorrhages and superficial siderosis. (PubMed, Alzheimers Dement (Amst)) - Sep 17, 2026 - "SWI identifies more exclusionary hemorrhagic findings and demonstrates greater reproducibility than GRE." 
Journal • CNS Disorders • Hematological Disorders
http://www.ncbi.nlm.nih.gov/pubmed/42745918
 
Benjamin Kozak; Esteban Calle Cadavid; Harry R Griffin; Javier Romero; Jeremy N Ford; John Dickson; Liliana A Ramirez Gomez; Marvin Relerford Iii; Maryam Vejdani-Jahromi; Matthew N DeSalvo; Odette Ganem Chagui; Raymond Y Huang; Saurabh Rohatgi; Seonghwan Yee; Suely Fazio Ferraciolli; Teresa Gomez-Isla
 
Sep 17, 2026
 
Prev Next